UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin

PloS one, 2018-05, Vol.13 (5), p.e0196911-e0196911

2018

Volltextzugriff (PDF)

Novel ELISA for the specific detection of protease NEXIN‐1 in human biological samples

Research and practice in thrombosis and haemostasis, 2022-07, Vol.6 (5), p.e12756-n/a, Article e12756

2022

Volltextzugriff (PDF)

Energy content and indirect greenhouse gas emissions embedded in ‘emission-free’ power plants: results for the Low Countries

Applied energy, 2000-11, Vol.67 (3), p.307-330

2000

Volltextzugriff (PDF)

Development of a genotype 325-specific proCPU/TAFI ELISA

Arteriosclerosis, thrombosis, and vascular biology, 2003-06, Vol.23 (6), p.1122-1127

2003

Volltextzugriff (PDF)

Development of ELISAs measuring the extent of TAFI activation

Arteriosclerosis, thrombosis, and vascular biology, 2006-02, Vol.26 (2), p.423-428

2006

Volltextzugriff (PDF)

Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis

Clinical and experimental dermatology, 2022-07, Vol.47 (7), p.1324-1336

2022

Volltextzugriff (PDF)

Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure

Thrombosis and haemostasis, 1996-11, Vol.76 (5), p.663-669

1996

Volltextzugriff (PDF)

Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy

Journal of investigative dermatology, 2019-10, Vol.139 (10), p.2232-2235.e1

2019

Volltextzugriff (PDF)

Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis

Journal of Crohn's and colitis, 2016-05, Vol.10 (5), p.575-581

2016

Volltextzugriff (PDF)

Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label

European journal of gastroenterology & hepatology, 2021-01, Vol.33 (1), p.54-61

2021

Volltextzugriff (PDF)

An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases

Inflammatory bowel diseases, 2015-09, Vol.21 (9), p.2172-2177

2015

Volltextzugriff (PDF)

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Journal of pharmaceutical and biomedical analysis, 2020-09, Vol.189, p.113433-113433, Article 113433

2020

Volltextzugriff (PDF)

Validation of a sample pretreatment protocol to convert a drug‐sensitive into a drug‐tolerant anti‐infliximab antibody immunoassay

Drug testing and analysis, 2017-02, Vol.9 (2), p.243-247

2017

Volltextzugriff (PDF)

Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays

Therapeutic drug monitoring, 2015-08, Vol.37 (4), p.479-485

2015

Volltextzugriff (PDF)

Characterization and Application of a Unique Panel of Monoclonal Antibodies Generated against Etanercept

The Journal of immunology (1950), 2016-03, Vol.196 (6), p.2879-2884

2016

Volltextzugriff (PDF)

Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays

Journal of pharmaceutical and biomedical analysis, 2016-06, Vol.125, p.62-67

2016

Volltextzugriff (PDF)

Golimumab Trough Levels Predict Mucosal Healing and Success of Dose Optimization: A Prospective Observational Study: 737

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S415-S416

2018

Volltextzugriff (PDF)

Sa1943 Variability in Vedolizumab Exposure Between Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S411-S412

2016

Volltextzugriff (PDF)

Mo1880 - Ustekinumab Induces Limited Mucosal Healing after 6 Months in a Real-Life, Prospective Cohort of Patients with Refractory Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-836-S-836

2018

Volltextzugriff (PDF)

Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization

Therapeutic drug monitoring, 2014-10, Vol.36 (5), p.669-673

2014

Volltextzugriff (PDF)

Sa1878 - Recent Anti-TNF Exposure Predicts Lower Vedolizumab Trough Concentrations in Patients with Crohn Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S380-S380

2017

Volltextzugriff (PDF)

Recent Anti-TNF Exposure Predicts Lower Vedolizumab Trough Concentrations in Patients with Crohn Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S380-S380

2017

Volltextzugriff (PDF)

Identification of a Target Site in Plasminogen Activator Inhibitor-1 That Allows Neutralization of Its Inhibitory Properties Concomitant with an Allosteric Up-regulation of Its Antiadhesive Properties

The Journal of biological chemistry, 2001-07, Vol.276 (28), p.26243-26248

2001

Volltextzugriff (PDF)

Selective neutralization of the serpin protease nexin‐1 by a specific monoclonal antibody

British journal of haematology, 2016-02, Vol.172 (4), p.631-633

2016

Volltextzugriff (PDF)

Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples

Thrombosis and haemostasis, 2000-12, Vol.84 (6), p.1082-1086

2000

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin

Novel ELISA for the specific detection of protease NEXIN‐1 in human biological samples

Energy content and indirect greenhouse gas emissions embedded in ‘emission-free’ power plants: results for the Low Countries

Development of a genotype 325-specific proCPU/TAFI ELISA

Development of ELISAs measuring the extent of TAFI activation

Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis

Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure

Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy

Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis

Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label

An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Validation of a sample pretreatment protocol to convert a drug‐sensitive into a drug‐tolerant anti‐infliximab antibody immunoassay

Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays

Characterization and Application of a Unique Panel of Monoclonal Antibodies Generated against Etanercept

Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays

Golimumab Trough Levels Predict Mucosal Healing and Success of Dose Optimization: A Prospective Observational Study: 737

Sa1943 Variability in Vedolizumab Exposure Between Patients With Inflammatory Bowel Disease

Mo1880 - Ustekinumab Induces Limited Mucosal Healing after 6 Months in a Real-Life, Prospective Cohort of Patients with Refractory Crohn's Disease

Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization

Sa1878 - Recent Anti-TNF Exposure Predicts Lower Vedolizumab Trough Concentrations in Patients with Crohn Disease

Recent Anti-TNF Exposure Predicts Lower Vedolizumab Trough Concentrations in Patients with Crohn Disease

Identification of a Target Site in Plasminogen Activator Inhibitor-1 That Allows Neutralization of Its Inhibitory Properties Concomitant with an Allosteric Up-regulation of Its Antiadhesive Properties

Selective neutralization of the serpin protease nexin‐1 by a specific monoclonal antibody

Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples

Suchergebnisse filtern